HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Peter S Fail Selected Research
Peter S Fail Research Topics
Disease
3
Heart Failure
01/2022 - 01/2018
3
Chronic Limb-Threatening Ischemia
08/2005 - 12/2004
2
Cardiomyopathies (Cardiomyopathy)
01/2023 - 01/2022
2
Hemorrhage
08/2014 - 06/2003
2
Acute Coronary Syndrome
08/2014 - 08/2005
2
Peripheral Vascular Diseases (Peripheral Vascular Disease)
08/2005 - 06/2003
1
Myocardial Infarction
08/2014
1
Mitral Valve Insufficiency (Mitral Regurgitation)
07/2013
1
Thrombosis (Thrombus)
08/2005
1
Chronic Renal Insufficiency
08/2005
1
Thrombophilia
08/2005
1
Inflammation (Inflammations)
08/2005
1
Aneurysm (Aneurysms)
03/2004
1
Endoleak
03/2004
1
Neoplasms (Cancer)
08/2003
Drug/Important Bio-Agent (IBA)
3
salicylhydroxamic acid (SHAM)
IBA
01/2022 - 01/2018
2
Brain Natriuretic Peptide (Natrecor)
FDA Link
01/2023 - 01/2022
2
bivalirudin (Angiomax)
FDA Link
08/2005 - 06/2003
1
high fluorescent intermediate II
IBA
01/2022
1
pro-brain natriuretic peptide (1-76)
IBA
01/2022
1
RB 007
IBA
08/2014
1
Heparin (Liquaemin)
FDA Link
Generic
08/2014
1
Factor IXa (Coagulation Factor IXa)
IBA
08/2014
1
RB 006
IBA
08/2014
1
Thrombin
FDA Link
08/2005
1
Tirofiban (Aggrastat)
FDA Link
08/2005
1
Platelet Membrane Glycoprotein IIb
IBA
08/2005
1
Anticoagulants
IBA
06/2003
Therapy/Procedure
2
Stents
03/2004 - 08/2003
1
Percutaneous Coronary Intervention
08/2014
1
Cardiopulmonary Bypass (Heart-Lung Bypass)
07/2013
1
Limb Salvage
05/2005
1
Thrombectomy
12/2004
1
Therapeutics
12/2004
1
Length of Stay
06/2003